Jared Kelly
Chief Executive Officer at Oncolytics Biotech Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 10 months
- Director since
- 2026
10 months of board service in total across 1 board, counting each seat separately. Longest: Oncolytics Biotech Inc., 10 months.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 12, 2026 | Oncolytics Biotech Inc. | Open-market purchase | +5,050 | $0.96 | $4,848 |
| Feb 12, 2026 | Oncolytics Biotech Inc. | Open-market purchase | +29,500 | $0.84 | $24,780 |
| Feb 11, 2026 | Oncolytics Biotech Inc. | Open-market purchase | +5,600 | $0.84 | $4,704 |
Questions about Jared Kelly
What boards is Jared Kelly on?
Jared Kelly sits on the board of Oncolytics Biotech Inc.
What company is Jared Kelly the CEO of?
Jared Kelly has been Chief Executive Officer of Oncolytics Biotech Inc. since January 2026.
How long has Jared Kelly served on boards?
Our records show at least 10 months of board service across 1 board, the earliest from 2026.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.